Analysts' average 12-month price target for Chemours Company is $19.
Get informed when a big investor buys or sells
+ Follow$14.53
6 analysts in the last 4 months
High: $22 | Low: $17
No recommendations in the last 4 months.
Chemours Company posts a target price of $19. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
A target price of $19 for CC means covering analysts, on average, see the stock 31.9% upside of $14.53 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.
Context for CC's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Chemours Company's other metric pages and overview cover the third.
Judging Chemours Company against Consumer Discretionary peers is usually better than using a market-wide rule of thumb. Business models inside Consumer Discretionary are more comparable, which makes gaps in target price easier to interpret. Start with $19 here, then scan peer and history charts to see if the gap is persistent.